HLA Class-II?Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients. (2021)

First Author: Zhao Q
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2021.03.014

PubMed Identifier: 33798536

Publication URI: http://europepmc.org/abstract/MED/33798536

Type: Journal Article/Review

Volume: 141

Parent Publication: The Journal of investigative dermatology

Issue: 10

ISSN: 0022-202X